Empowered Funds
PMVP icon

Empowered Funds’s PMV Pharmaceuticals PMVP Stock Holding History

Empowered Funds’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$126K Buy
+75,575
New +$97.9K ﹤0.01% 2381

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Affinity Asset Advisors
Affinity Asset Advisors New York $2.46B AUM 196.28% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
BIT Capital
BIT Capital Berlin, Germany $2.89B AUM 111.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Aldebaran Capital
Aldebaran Capital Carmel, Indiana $139M AUM 35.88% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $109B AUM 29.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Empowered Funds's PMVP Position: Q3 2026 in Review

Empowered Funds opened a new position in PMV Pharmaceuticals (PMVP) in Q3 2026: 75,575 shares worth $126K. The stake represents ﹤0.01% of the portfolio and ranks #2381 among its holdings.

36 funds tracked by Wall St. Rank hold PMVP as of Q3 2026.

  • Empowered Funds held 75,575 shares of PMV Pharmaceuticals worth $126K as of Q3 2026.
  • PMV Pharmaceuticals was a new Empowered Funds position in Q3 2026.
  • PMV Pharmaceuticals made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2381 holding.
  • 36 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2026.

Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.